This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Closed Blood Sampling Systems Market

Closed Blood Sampling Systems Market

Closed Blood Sampling Systems Market Analysis by Sampling System (Single-line, Double-Line, Triple-Line, Pressure Transducer/ Monitoring Kits), by Modality (Arm-mounted, Pole-mounted), by Age Group (Neonatal/Pediatrics, Adults), by End-user & Regional Forecast to 2032

Closed Blood Sampling Systems Market
FACT4002MR
  • Mar-2022
  • List of Tables : 48
  • List of Figures : 255
  • 170 Pages
  • Healthcare

Closed Blood Sampling Systems Market Outlook (2022-2032)

Global demand for closed blood sampling systems is slated to experience significant growth at 5.9% CAGR from 2021 to 2032, with the market value set to increase from US$ 76.32 Mn in 2022 to US$ 135.83 Mn by the end of 2032.

Report Attributes

Details

Closed Blood Sampling Systems Market Size (2021A)

US$ 72.64 Mn

Estimated Market Value (2022E)

US$ 76.32 Mn

Forecasted Market Value (2032F)

US$ 135.83 Mn

Global Market Growth Rate (2022-2032)

5.9% CAGR

East Asia Market Share (2021)

~ 14.5%

East Asia Growth Rate (2022-2032)

6.9% CAGR

China Growth Rate (2022-2032)

7.6% CAGR

Market Share of Top 3 Countries

~47.5%

Key Companies Profiled

  • ICU Medical, Inc.
  • Smiths Medical, Inc.
  • Edwards Lifesciences Corporation
  • Merit Medical Systems
  • Utah Medical Products, Inc.
  • Elcam Medical
  • CardioMed Supplies Inc.
  • Shenzhen Antmed Co., Ltd.

As per Fact.MR’s projections, single-line blood sampling systems held a substantial market share of 25.5% in 2021. Closed blood sampling systems accounted for around 0.3% share of the global blood screening market in 2021.

Avail customized purchase options for your needs

Sales Analysis of Closed Blood Sampling Systems from 2017 to 2021 Vs Market Outlook for 2022 to 2032

The global closed blood sampling systems market expanded at 4.8% CAGR over the past 5 years.

Demand for closed blood sampling systems depends upon the global factors associated with rising measures by healthcare facilities towards comprehensive surgical care. Surgical care is a prime and essential practice to effectively manage a varied range of health conditions.

Increasing cases of injury and wound, malignancy, chronic diseases such as cardiovascular diseases and diabetes, obstructed labor, and infections, globally, have accelerated demand for safe and efficient blood sampling techniques, thus posing a positive impact on the growth of the closed blood sampling devices market.

Moreover, lower income economies present a lucrative opportunity for the demand growth of closed blood sampling systems. Market growth is driven by advancements in closed blood sampling systems, allowing contamination-free blood sampling as well as the prevention of needle stick injury to the provider.

Additionally, closed blood sampling systems, as opposed to conventional blood sampling systems, provide a cost-efficient process of sampling, with restricted to no access to the external environment that would otherwise result in sampling errors.

Thus, growing number of global surgical procedures due to rise in chronic diseases and infections is associated with the enhancement of the closed blood sampling systems market share.

With the advent of COVID-19, a rise in the number of intensive care admissions was observed across the world. High rate of mortality linked to increasing number of intensive care admissions due to the rising burden of disease functions as another major factor driving consumption of closed blood sampling systems.

Furthermore, keeping in account the large base of trauma cases within the global healthcare sphere, timely blood transfusion is a vital process in providing patients with stabilized hemodynamic variables for further assessment and treatment processes. The benefits of closed blood sampling systems for adults in trauma cases as well as in severely-ill patients with anemia is an essential motive to spare avoidable blood loss and contamination.

This further promotes the need for closed blood sampling systems, owing to their convenience, precision, and mitigation of contamination of samples, as well as prevention of infections associated with needle stick injuries. Key players in the closed blood sampling systems market are working towards new device development along with integrated systems to display patient dynamics such as vitals.

Sales revenue from closed blood sampling systems are expected to increase at a considerable growth rate over the next ten years at a CAGR of 5.9%.

Closed blood sampling systems market sampling system forecast by Fact.MR

What are the Key Opportunities for Closed Blood Sampling Equipment Manufacturers?

“Emergence of Needleless Blood Sampling Systems”

Key opportunities for closed blood sampling system providers include novel approaches towards the prevention of occupational injuries such as needle stick injuries. This factor is expected to stimulate a lucrative opportunity for the growth of the closed blood sampling systems market, owing to the provisions of needleless blood sampling systems, thus aiding in the prevention of infections associated with exposure to needle sticks.

Moreover, the design and engineering of new closed blood sampling systems for neonates and paediatric patients has aided physicians in managing the care of at-risk patients with error-free procedures of blood sampling. These advancements play a vital role in critical care cases with the added-upon options to manage close hemodynamic monitoring and provide accurate output readings.

Through advancements in closed blood sampling devices with improved medical device technology and the incorporation of automation into medical systems, upsurge in the development of closed blood sampling systems with tailored applications for specific procedures related to a disease indication is pacing up.

“Rising Cases of Chronic Diseases Demanding Enhanced Patient Care”

Rising incidence of chronic diseases and demand for enhanced patient care and safety are set to urge manufacturers to widen their product offerings to incorporate the incongruous demands of patient-specific procedures with respect to blood sampling.

These factors collectively produce an opportunistic growth opportunity for closed blood sampling system manufacturers over the forecast period, and are expected to contribute towards enhanced patient treatment outcomes across the world.

An Adaptive Approach to Modern-day Research Needs

What Factors are Restraining Demand Growth of Closed Blood Sampling Systems?

“Dearth of Skilled Professionals & Less Product Awareness in Developing Nations”

Various restraints associated with the demand growth of closed blood sampling systems include rising global burden of disease, increasing incidence of infectious diseases, especially within low-income economies, and lack of adoption of closed blood sampling systems in these countries as compared to developed countries with established and evolving healthcare infrastructure.

There exists lack of awareness linked to the advantages associated with the adoption of advanced closed systems for blood sampling procedures and the considered cost-effectiveness for routine procedures within hospital settings. Piling onto this factor, lack of presence of professionals skilled with the understanding and guidelines related to advanced closed blood sampling systems and their implementation is another major restraint associated with market growth potential.

There also exists a scarcity of standardized global guidelines for the execution of effective blood sampling. Many countries support recommendations only if they come from a regulatory body.

All these factors thus compile into some major restraints related to the growth in the sales and demand for closed blood sampling devices.

Closed blood sampling systems market region forecast by Fact.MR

Country-wise Insights

Why is the U.S. a Huge Market for Closed Blood Sampling Systems?

The U.S. closed blood sampling systems market dominated the North American region with 91.2% share in 2021, and is projected to continue experiencing high growth throughout the forecast period.

Growth of this market is driven by rapidly rising awareness regarding safe blood sampling and its advantages in mitigating sample contamination and prevention of infections associated with occupational injuries.

Will Germany Be a Lucrative Market for Suppliers of Closed Blood Sampling Systems in Europe?

Germany is set to dominate the Europe closed blood sampling systems market with a share of 23.5% by 2032. Demand for closed blood sampling devices in Germany is associated with high willingness and ability of the population to spend on wellness owing to rising per capita healthcare spending.

Advanced methods are increasingly being established in the outpatient and inpatient sector. The benefits of closed blood sampling systems for diagnostics, their high quality, and excellent effectiveness have led to high demand in the country, owing to their proven efficiency during clinical trials.

How is the China Closed Blood Sampling Systems Market Faring?

In 2021, China held 43.3% share in the East Asia closed blood sampling systems market, and the market is projected to expand at a CAGR of 7.6% from 2022 to 2032.

Market stance that China currently possesses is owed to the country being a large production entity in the medical devices industry, with major industry players establishing their manufacturing units within the country at lower costs with efficient supply management.

Interested to Procure The Data

Category-wise Insights

Which Closed Blood Sampling System is Driving Most Market Growth?

Single-line blood sampling systems accounted for the highest share of around 25.5% in 2021, and demand projects lucrative growth at a CAGR of around 6.3% through 2032.

Single-line blood sampling systems benefit users with properties such as prevention of IV line contamination and blood loss. Demand for single-line blood sampling devices is projected to exceed the sales of double-line blood sampling systems by the end of the forecast period.

Which Modality is Most Adopted in Closed Blood Sampling Systems?

Demand of pole-mounted sampling systems is high and held a market value share of 67% in 2021, with the segment set to advance at a CAGR of 5.4%.

Within the healthcare setting, pole-mounted sampling systems provide effective assessment of a patient’s vitals along with performing error-free blood sampling and blood transfusion processes.

Arm-mounted sampling system demand is expected to gain traction over the forecast period; however, adoption of pole-mounted sampling systems is still predicted to possess a dominant stand in the market in terms of modality.

Which Age Group Drives Most Demand for Closed Blood Sampling Systems?

Adults reflected a higher market value share of around 67.8% in 2021, and are expected to show a higher market value over the paediatric/neonatal age group, rising at a CAGR of 5.5% through 2032. A large ratio of the global adult population group suffers from chronic disease and ailments associated with infectious diseases.

Moreover, increasing age is also associated with high prevalence of injury and wounds. Management of such conditions has influenced the growth output of closed blood sampling products, globally.

Competitive Landscape

Prominent manufacturers of closed blood sampling systems focus on research and development, collaborations, and new product launches, which have emerged as key growth strategies.

  • In January 2021, Inventis, an Italian company founded in 2005 with its headquarters in Padua, which designs and manufactures advanced audiological diagnostics equipment, announced that it has acquired 100% share capital of Synapsys, a French leader in balance diagnostic systems.
  • In June 2018, Interacoustics A/S launched a new Micromedical Orion Rotary Chair for enhanced vestibular assessment.

Similarly, recent developments related to companies manufacturing closed blood sampling products have been tracked by the team at Fact.MR, which are available in the full report.

Key Segments Covered in Closed Blood Sampling Systems Industry Research

  • Closed Blood Sampling Systems Market by Sampling System:

    • Single-line Blood Sampling Systems
    • Double-Line Blood Sampling Systems
    • Triple-Line Blood Sampling Systems
    • Pressure Transducer/ Monitoring Kits
    • Accessories
  • Closed Blood Sampling Systems Market by Modality:

    • Arm-mounted Sampling Systems
    • Pole-mounted Sampling Systems
  • Closed Blood Sampling Systems Market by Age Group:

    • Neonatal/Pediatrics
    • Adults
  • Closed Blood Sampling Systems Market by End User:

    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Cancer Research Institutes
    • Blood Banks
    • Others
  • Closed Blood Sampling Systems Market by Region:

    • North America Closed Blood Sampling Systems Market
    • Latin America Closed Blood Sampling Systems Market
    • Europe Closed Blood Sampling Systems Market
    • South Asia Closed Blood Sampling Systems Market
    • East Asia Closed Blood Sampling Systems Market
    • Oceania Closed Blood Sampling Systems Market
    • MEA Closed Blood Sampling Systems Market

- FAQs -

The global closed blood sampling systems market is worth US$ 72.6 Mn at present, and is set to expand 1.8X over the next ten years.
Closed blood sampling device sales are expected to reach US$ 135.8 Mn by the end of 2032, with sales revenue expected to register 5.9% CAGR.
From 2017-2021, the market for closed blood sampling equipment expanded at 4.8%, owing to increasing awareness regarding prevalence of needle stick injuries.
Latest trends related to closed blood sampling systems include rising demand for safe blood collection techniques and increasing needle stick injuries promoting the use of needle-free sampling devices.
The U.S., Germany, U.K., China, and France are expected to drive most demand for closed blood sampling products.
North America is one of the key markets for closed blood sampling systems, with the U.S. expected to account 92.6% of the North American market by 2032.
Demand for closed blood sampling systems in Europe is expected to register a CAGR of 5.5% over the next ten years.
The U.S., France, and U.K. are key producers of closed blood systems products.

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Lung Monitoring Devices Market

Lung Monitoring Devices Market is expected to witness growth during 2021-2031, owing to continuous i...

Intraoperative sensor Market

Intraoperative Sensor Market to gain traction during the years, 2021-2031. Increasing prevalence of ...

Neonatal Monitoring Equipment Market

[170 Pages Report] Neonatal Monitoring Equipment Market research report categorizes the global marke...

Europe Patient Positioning System Market

Europe Patient Positioning System Market is projected to register 4.5% CAGR and reach US$ 448.6 Mill...

- Our Clients -

Report Client